HSBC Holdings’s VanEck Biotech ETF BBH Stock Holding History

HSBC Holdings’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,017	Closed	-$728K	–	2049
2016 Q1	$728K	Buy	7,017 +795	+13%	+$82.9K	﹤0.01%	1424
2015 Q4	$790K	Sell	6,222 -225	-3%	-$27.6K	﹤0.01%	1526
2015 Q3	$737K	Buy	6,447 +2,235	+53%	+$296K	﹤0.01%	1295
2015 Q2	$568K	Buy	4,212 +2,534	+151%	+$337K	﹤0.01%	1388
2015 Q1	$217K	Buy	+1,678	New	+$211K	﹤0.01%	1895

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HSBC Holdings's BBH Position: Q2 2016 in Review

HSBC Holdings sold out of VanEck Biotech ETF (BBH) in Q2 2016, closing a stake of 7,017 shares — an estimated $728K sold.

HSBC Holdings first reported a position in BBH in Q1 2015 and held it in 5 quarters. The position peaked at $790K in Q4 2015. 78 funds tracked by Wall St. Rank hold BBH as of Q2 2016.

HSBC Holdings reported no remaining VanEck Biotech ETF position as of Q2 2016 after selling out during the quarter.
HSBC Holdings sold 7,017 VanEck Biotech ETF shares in Q2 2016, an estimated $728K.
HSBC Holdings first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 5 quarters.
HSBC Holdings's VanEck Biotech ETF position peaked at $790K in Q4 2015.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2016.

Based on HSBC Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.